Patents by Inventor Cullen L. Schmid

Cullen L. Schmid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Signaling-biased mu opioid receptor agonists
    Patent number: 10751335
    Abstract: The invention provides—opioid receptor agonists that are analgesic agents and that promote diminished side effects relative to a comparably effective dose of morphine. The side effects that are absent or attenuated include one or more of the following: constipation, respiratory depression, tolerance, dependence, nausea, confusion, sedation, hypotension, and post-treatment withdrawal symptoms.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: August 25, 2020
    Assignee: THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Thomas D. Bannister, Laura M. Bohn, Cullen L. Schmid
  • SIGNALING-BIASED MU OPIOID RECEPTOR AGONISTS
    Publication number: 20190055214
    Abstract: The invention provides—opioid receptor agonists that are analgesic agents and that promote diminished side effects relative to a comparably effective dose of morphine. The side effects that are absent or attenuated include one or more of the following: constipation, respiratory depression, tolerance, dependence, nausea, confusion, sedation, hypotension, and post-treatment withdrawal symptoms.
    Type: Application
    Filed: March 15, 2017
    Publication date: February 21, 2019
    Inventors: Thomas D. Bannister, Laura M. Bohn, Cullen L. Schmid